Study of Functional and Aesthetic Outcomes After Wassel IV Thumb Duplication Surgery in Pediatric Population, With a Follow-up of at Least One Year
Launched by UNIVERSITY HOSPITAL, GRENOBLE · Apr 17, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well surgery works for children with a condition called Wassel IV thumb duplication, which means they have an extra thumb or a thumb that is not formed correctly. The researchers want to see both how the thumb functions after surgery and how it looks, focusing on children between 1 and 18 years old. The study will follow participants for at least a year after their surgery to gather information about their progress.
To participate in this study, children must have a confirmed diagnosis of Wassel IV thumb duplication and be able to provide consent from their legal guardians. Those who are under guardianship or whose guardians do not agree to the study will not be eligible. Participants will have regular check-ups with their surgeon after the surgery, and the study will collect important medical information, including photos and X-rays, to evaluate their results. This research aims to improve understanding of how to best treat this condition in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed diagnosis of Wassel IV thumb duplication
- • Pediatric patients aged between 1 and 18 years
- • Minimum of one year post-operative follow-up
- • Availability of radiographic, photographic, and medical data
- • Regular post-operative medical follow-up with the referring surgeon
- • Legal guardian and patient consent (non-opposition) to participate in the study
- Exclusion Criteria:
- • Subjects under guardianship or deprived of liberty
- • Opposition from legal guardians or from the patient to participate in the study
About University Hospital, Grenoble
The University Hospital of Grenoble is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to facilitate cutting-edge studies that aim to improve treatment outcomes and enhance patient safety. With a strong commitment to collaboration, the University Hospital of Grenoble engages in partnerships with academic institutions, industry leaders, and regulatory bodies to drive scientific discovery and translate research findings into clinical practice. Its state-of-the-art facilities and multidisciplinary teams ensure rigorous adherence to ethical standards and regulatory guidelines, fostering an environment where groundbreaking research can thrive.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported